The final summary of the Pfizer’s six-month clinical trial data—the document that Pfizer submitted to FDA to win approval—revealed one key data point that should have killed that intervention forever. Far more people died in the vaccine group than in the placebo group during Pfizer’s clinical trials. The fact that FDA nevertheless granted Pfizer full approval, and that the medical community embraced and prescribed this intervention for their patients, is eloquent testimony to the resilience of even the most deadly and inefficacious products, and the breathtaking power of the pharmaceutical
...more
